Caas Capital Management LP Dexcom Inc Call Options Transaction History

Caas Capital Management LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 26, 2024	SELL	$114.22 - $140.1 $1.11 Million - $1.36 Million	-9,700 Reduced 83.62%	1,900 $263,000
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $875,683 - $1.44 Million	11,600 New	11,600 $1.44 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $5.47 Million - $6.47 Million	-52,600 Reduced 77.35%	15,400 $1.79 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $3.47 Million - $6.78 Million	51,000 Added 300.0%	68,000 $5.07 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $84,672 - $117,179	-900 Reduced 5.03%	17,000 $8.7 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $1.38 Million - $1.85 Million	17,100 Added 2137.5%	17,900 $7.64 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $200,576 - $337,088	-3,200 Reduced 80.0%	800 $324,000
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $191,160 - $302,520	4,000 New	4,000 $1.08 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.